(Reuters) – Johnson & Johnson (NYSE:) stated on Tuesday it might purchase clinical software maker V-Stream in a trade in probably significance as much as $1.1 billion, marking the untouched acquisition to reinforce its units unit.
J&J stated it’s going to pay $600 million prematurely, with the remainder of the bills contingent on regulatory and industrial milestones.
